|
:''Not to be confused with Metaxalone, a muscle relaxant.'' Metolazone is a thiazide-like diuretic marketed under the brand names Zytanix from Zydus Cadila, Zaroxolyn, and Mykrox. It is primarily used to treat congestive heart failure and high blood pressure. Metolazone indirectly decreases the amount of water reabsorbed into the bloodstream by the kidney, so that blood volume decreases and urine volume increases. This lowers blood pressure and prevents excess fluid accumulation in heart failure. Metolazone is sometimes used together with loop diuretics such as furosemide or bumetanide, but these highly effective combinations can lead to dehydration and electrolyte abnormalities. ==History== Metolazone was developed in the 1970s. Its creator, Indian born chemist Dr. Bola Vithal Shetty has been active in helping the U.S. Food and Drug Administration review drug applications, and in the development of new medicines.〔Katague, David B. "Chemistry Reviewer Still in Lab". ''News Along the Pike'' (newsletter of the Food and Drug Administration' s Center for Drug Evaluation and Research). Volume 2, Issue 10. (PDF ). Accessed on January 25, 2006.〕 Metolazone quickly gained popularity due to its lower renal toxicity compared to other diuretics (especially thiazides) in patients with renal insufficiency. It is marketed as various brands such as MELA by RPG Lifesciences and Zytanix by Zydus. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Metolazone」の詳細全文を読む スポンサード リンク
|